New Results
LY-CoV1404 potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Stefanie Žentelis, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole Kalleward, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Courtney Cohen, John Dye, Kathleen I. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Lingshu Wang, Eun Sung Yang, Yi Zhang, Wei Shi, Barney S. Graham, John R. Mascola, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, Bryan E. Jones, Bryan C. Barnhart
doi: https://doi.org/10.1101/2021.04.30.442182
Kathryn Westendorf
1AbCellera Biologics Inc., Vancouver, BC, Canada
Stefanie Žentelis
1AbCellera Biologics Inc., Vancouver, BC, Canada
Denisa Foster
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Peter Vaillancourt
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Matthew Wiggin
1AbCellera Biologics Inc., Vancouver, BC, Canada
Erica Lovett
1AbCellera Biologics Inc., Vancouver, BC, Canada
Jörg Hendle
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Anna Pustilnik
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
J. Michael Sauder
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Lucas Kraft
1AbCellera Biologics Inc., Vancouver, BC, Canada
Yuri Hwang
1AbCellera Biologics Inc., Vancouver, BC, Canada
Robert W. Siegel
3Eli Lilly and Company, Indianapolis, IN, USA
Jinbiao Chen
3Eli Lilly and Company, Indianapolis, IN, USA
Beverly A. Heinz
3Eli Lilly and Company, Indianapolis, IN, USA
Richard E. Higgs
3Eli Lilly and Company, Indianapolis, IN, USA
Nicole Kalleward
3Eli Lilly and Company, Indianapolis, IN, USA
Kevin Jepson
1AbCellera Biologics Inc., Vancouver, BC, Canada
Rodrigo Goya
1AbCellera Biologics Inc., Vancouver, BC, Canada
Maia A. Smith
1AbCellera Biologics Inc., Vancouver, BC, Canada
David W. Collins
1AbCellera Biologics Inc., Vancouver, BC, Canada
Davide Pellacani
1AbCellera Biologics Inc., Vancouver, BC, Canada
Ping Xiang
1AbCellera Biologics Inc., Vancouver, BC, Canada
Valentine de Puyraimond
1AbCellera Biologics Inc., Vancouver, BC, Canada
Marketa Ricicova
1AbCellera Biologics Inc., Vancouver, BC, Canada
Lindsay Devorkin
1AbCellera Biologics Inc., Vancouver, BC, Canada
Caitlin Pritchard
1AbCellera Biologics Inc., Vancouver, BC, Canada
Aoise O’Neill
1AbCellera Biologics Inc., Vancouver, BC, Canada
Courtney Cohen
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
John Dye
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
Kathleen I. Huie
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
Catherine V. Badger
5U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, 21702, USA
Darwyn Kobasa
6National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
7University of Manitoba, Winnipeg, Manitoba, Canada
Jonathan Audet
6National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
7University of Manitoba, Winnipeg, Manitoba, Canada
Joshua J. Freitas
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Saleema Hassanali
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Ina Hughes
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Luis Munoz
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Holly C. Palma
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Bharathi Ramamurthy
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Robert W. Cross
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Thomas W. Geisbert
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Viktoriya Borisevich
8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA
Iliana Lanz
1AbCellera Biologics Inc., Vancouver, BC, Canada
Lisa Anderson
1AbCellera Biologics Inc., Vancouver, BC, Canada
Payal Sipahimalani
1AbCellera Biologics Inc., Vancouver, BC, Canada
Kizzmekia S. Corbett
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Lingshu Wang
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Eun Sung Yang
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Yi Zhang
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Wei Shi
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Barney S. Graham
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
John R. Mascola
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Tara L. Fernandez
1AbCellera Biologics Inc., Vancouver, BC, Canada
Carl L. Hansen
1AbCellera Biologics Inc., Vancouver, BC, Canada
Ester Falconer
1AbCellera Biologics Inc., Vancouver, BC, Canada
Bryan E. Jones
2Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA
Bryan C. Barnhart
1AbCellera Biologics Inc., Vancouver, BC, Canada
Article usage
Posted May 04, 2021.
LY-CoV1404 potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Stefanie Žentelis, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole Kalleward, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Courtney Cohen, John Dye, Kathleen I. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Lingshu Wang, Eun Sung Yang, Yi Zhang, Wei Shi, Barney S. Graham, John R. Mascola, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, Bryan E. Jones, Bryan C. Barnhart
bioRxiv 2021.04.30.442182; doi: https://doi.org/10.1101/2021.04.30.442182
LY-CoV1404 potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Stefanie Žentelis, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole Kalleward, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Courtney Cohen, John Dye, Kathleen I. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Lingshu Wang, Eun Sung Yang, Yi Zhang, Wei Shi, Barney S. Graham, John R. Mascola, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, Bryan E. Jones, Bryan C. Barnhart
bioRxiv 2021.04.30.442182; doi: https://doi.org/10.1101/2021.04.30.442182
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29194)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18305)
- Genetics (12245)
- Genomics (16801)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60962)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)